Skip to main content

Table 1 Study measures

From: Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy

  1. 1Acute treatments are delivered 2-3 times a week. Acute assessments are delivered after every 3-4 treatments
  2. 2≤ 4 days post-acute phase
  3. Abbreviations:
  4. MINI International Neuropsychiatric Interview diagnosis V6.0 (MINI), Transcranial Magnetic Stimulation Adult Safety Screen (TASS), 24-item Hamilton Depression Rating Scale (HRSD-24), Antidepressant Treatment History Form (ATHF), Scale for Suicidal Ideation (SSI), Brief Symptom Inventory (BSI), Clinical Global Impression Scale (CGI), Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q), Young Mania Rating scale (YMRS), Test of Premorbid Function (TOPF), Montreal Cognitive Assessment (MoCA), Delis Kaplan Executive Function System (DKEFS), California Verbal Learning Test- Third Edition (CVLT-3), Autobiographical Memory Test (AMT), National Institutes of Health (NIH) Toolbox: Flanker Inhibitory Control and Attention Test, Picture Sequence Memory Test, List Sorting Working Memory Test